Mettler Toledo (MTD)

NYSE Health Care Life Sciences Tools & Services S&P 500
$1,722.15
+43.07 (+2.57%)
Close of Nov 06, 2026 · end-of-day data

MTD 8-K filings in 2026

Every material Form 8-K Mettler Toledo filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2026716 on record in all
Latest filing in 2026Nov 05, 2026earnings
High impact (4-5)4of 7 briefs
TonePositive4Neutral3
leadership 3earnings 2guidance 2
Nov 5, 4:33 PM ET

Mettler-Toledo Reports Third Quarter 2026 Results and Raises Full-Year Guidance

Positive earnings 2.02

Mettler-Toledo International Inc. reported third quarter 2026 net sales of $1.094 billion, representing a 6% increase compared to the prior-year period. Diluted earnings per share rose to $12.29 from $10.57, while adjusted EPS grew 13% to $12.57, driven by improving market demand and solid execution. Management also raised its full-year 2026 adjusted EPS guidance range to $47.70 to $47.90.

  • Reported net sales for the third quarter of 2026 increased 6% to $1.094 billion.
  • Diluted earnings per share were $12.29, compared with $10.57 in the third quarter of 2025.
  • Adjusted diluted EPS increased 13% to $12.57 from $11.15 in the prior-year period.
  • Full-year 2026 adjusted EPS is forecast to be between $47.70 and $47.90.
Read the filing on SEC.gov ↗
Aug 3, 4:48 PM ET

Mettler-Toledo appoints Natalia Shuman to board, increasing size to ten directors

Neutral leadership Written later 5.027.01

Mettler-Toledo said its Board appointed Natalia Shuman as an independent director effective August 3, 2026, and increased the Board from nine to ten directors. The filing does not yet state which Board committees she will serve on, and it reports no financial results or guidance.

  • Natalia Shuman appointed director effective August 3, 2026; Board size increases from nine to ten
  • Board has deemed Ms. Shuman independent under NYSE listing standards
  • Ms. Shuman is President and CEO of MISTRAS Group since January 2025 and previously led Bureau Veritas North America from 2017 to 2021
  • Committee assignments have not yet been determined
Read the filing on SEC.gov ↗
Jul 30, 4:32 PM ET

Mettler-Toledo raises 2026 adjusted EPS forecast to $47.15-$47.50 after Q2 profit rise

Positive earnings Written later 2.02

Mettler-Toledo reported second-quarter 2026 sales of $1.027 billion, up 4% from a year earlier, and diluted EPS of $11.55 versus $9.76. Adjusted EPS was $11.46, up 14%, and the company raised its full-year 2026 adjusted EPS forecast to $47.15-$47.50 from $46.30-$46.95. Results include a one-time net tariff refund benefit that management excludes from its non-GAAP figures.

  • Q2 2026 reported sales rose 4% to $1.027 billion; local currency sales rose 6% excluding a one-time tariff refund to customers.
  • Diluted EPS was $11.55 (up from $9.76); adjusted EPS was $11.46 (up 14% from $10.09).
  • Full-year 2026 adjusted EPS forecast raised to $47.15-$47.50 from $46.30-$46.95; Q3 adjusted EPS forecast is $12.00-$12.15.
  • Non-GAAP results exclude a one-time $52 million IEEPA tariff refund benefit to cost of sales and a related $28 million refund to customers that reduced net sales.
Read the filing on SEC.gov ↗
May 13, 8:56 AM ET

Mettler-Toledo grants 2026 executive equity awards; CEO target LTI value up about 6.25%

Neutral leadership Written later 5.02

On May 7, 2026, Mettler-Toledo's Compensation Committee approved 2026 long-term incentive awards for its named executive officers, split into equal May and November 2026 grants. The May grant, dated May 12, 2026, raised the CEO's target LTI value by about 6.25% versus 2025 and the other named executive officers' by about 12.5%, which shows how the company is compensating its leadership team.

  • Awards mix one-third performance share units, one-third non-qualified stock options and one-third restricted stock units, with half granted in May 2026 and half in November 2026.
  • May 2026 grant to CEO Patrick Kaltenbach: 838 PSUs, 2,005 stock options and 810 RSUs, based on the May 12, 2026 closing price.
  • RSUs carry a 3-year cliff vesting schedule; vesting for PSUs and options is unchanged.
Read the filing on SEC.gov ↗
May 7, 4:33 PM ET

Mettler-Toledo Q1 EPS rises to $8.33; full-year adjusted EPS guidance raised

Positive guidance Written later 2.02

Mettler-Toledo reported first-quarter 2026 results on May 7, 2026, with reported sales up 7% to $947.1 million and GAAP diluted EPS of $8.33, compared with $7.81 a year earlier. Adjusted EPS rose 9% to $8.91. The company raised its full-year 2026 adjusted EPS forecast to $46.30 to $46.95 from $46.05 to $46.70, while its local currency sales growth forecast of about 4% was unchanged.

  • Reported sales rose 7% to $947.1 million; local currency sales rose 3%, or 1% excluding acquisitions.
  • GAAP diluted EPS was $8.33 versus $7.81; adjusted EPS was $8.91 versus $8.19, up 9%.
  • Full-year 2026 adjusted EPS forecast raised to $46.30 to $46.95 from $46.05 to $46.70.
  • Second-quarter 2026 adjusted EPS forecast is $10.70 to $10.85, with local currency sales growth of about 3%.
Read the filing on SEC.gov ↗
Feb 5, 4:39 PM ET

Mettler-Toledo Q4 sales rise 8%, adjusted EPS up 8%; 2026 EPS guidance raised

Positive guidance Written later 2.02

Mettler-Toledo reported fourth-quarter 2025 reported sales of $1.130 billion, up 8%, and adjusted EPS of $13.36, up 8%. For 2026 it forecasts adjusted EPS of $46.05 to $46.70, up from its prior range of $45.35 to $46.00, while keeping local currency sales growth guidance at about 4%. The company's full-year 2025 adjusted operating profit of $1.193 billion was slightly below the prior year's $1.200 billion.

  • Q4 2025 reported sales rose 8% to $1.130 billion; local currency sales rose 5%, including a 1% benefit from acquisitions.
  • Q4 2025 diluted EPS was $13.98 versus $11.96, including a non-cash discrete tax benefit of $0.95 per share; adjusted EPS was $13.36 versus $12.41.
  • Full-year 2025 reported sales rose 4% to $4.026 billion and adjusted EPS rose 4% to $42.73, while adjusted operating profit fell 1% to $1.193 billion.
  • 2026 adjusted EPS guidance is $46.05 to $46.70 versus the prior $45.35 to $46.00; first-quarter 2026 adjusted EPS is forecast at $8.60 to $8.75.
Read the filing on SEC.gov ↗
Jan 20, 5:02 PM ET

Mettler-Toledo Appoints Michael J. Tokich to Board of Directors, Effective February 5, 2026

Neutral leadership Written later 5.027.01

Mettler-Toledo said its Board appointed Michael J. Tokich as a director, effective February 5, 2026, and increased the Board from nine to ten members. Mr. Tokich is a former CFO of STERIS plc, and the filing describes him as independent under NYSE standards, a routine governance change with no financial results disclosed.

  • Board appointed Michael J. Tokich as director on January 16, 2026, effective February 5, 2026
  • Board size increased from nine to ten directors, effective February 5, 2026
  • Mr. Tokich served over 17 years as SVP and CFO at STERIS plc before recently moving to Senior Financial Advisor
  • Board has not yet decided which committees, if any, he will join
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Mettler Toledo filing is on SEC EDGAR ↗. 8-K briefs of other companies →